Pfiz­er signs up for match-mak­ing ser­vice; In­vestors tell Sanofi: Make a deal, now

• Pfiz­er has signed on with a “match-mak­er” group in Cam­bridge UK that spe­cial­izes in bring­ing bio­phar­ma com­pa­nies and aca­d­e­m­ic in­ves­ti­ga­tors to­geth­er. The Mil­ner Ther­a­peu­tics Con­sor­tium was set up in 2015, at­tract­ing GSK and As­traZeneca, among oth­ers, to the fold.

• Sanofi promised new M&A deals, but just can’t seem to pull a big one off. Two deals have slipped away now. And some of its big in­vestors are get­ting worked up about the lack of progress un­der CEO Olivi­er Brandi­court.  “The com­pa­ny needs a growth dri­ver and must make an ac­qui­si­tion. Time is run­ning out,” Olivi­er David of Ve­ga In­vest­ment Man­agers tells Reuters.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.